| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 1, Human | 107 | 2024 | 741 | 17.340 |
Why?
|
| Herpes Simplex | 50 | 2024 | 469 | 8.380 |
Why?
|
| Simplexvirus | 79 | 2015 | 804 | 7.080 |
Why?
|
| Immediate-Early Proteins | 44 | 2024 | 444 | 6.530 |
Why?
|
| Virus Replication | 88 | 2024 | 2450 | 6.210 |
Why?
|
| Viral Proteins | 95 | 2022 | 1798 | 6.060 |
Why?
|
| Gene Expression Regulation, Viral | 39 | 2024 | 434 | 5.550 |
Why?
|
| Herpesvirus 2, Human | 29 | 2021 | 191 | 5.100 |
Why?
|
| Virus Latency | 31 | 2021 | 359 | 3.790 |
Why?
|
| DNA, Viral | 46 | 2022 | 2196 | 3.760 |
Why?
|
| Herpes Genitalis | 17 | 2021 | 148 | 3.450 |
Why?
|
| Host-Pathogen Interactions | 22 | 2021 | 1463 | 3.030 |
Why?
|
| Genes, Immediate-Early | 6 | 2021 | 102 | 2.290 |
Why?
|
| Heterochromatin | 11 | 2023 | 294 | 2.280 |
Why?
|
| Vero Cells | 56 | 2018 | 481 | 2.200 |
Why?
|
| Genome, Viral | 16 | 2023 | 674 | 2.150 |
Why?
|
| Herpesvirus Vaccines | 6 | 2017 | 10 | 2.000 |
Why?
|
| Cell Nucleus | 33 | 2022 | 2864 | 1.970 |
Why?
|
| Phosphoproteins | 10 | 2023 | 2444 | 1.900 |
Why?
|
| Ubiquitin-Protein Ligases | 16 | 2023 | 1894 | 1.850 |
Why?
|
| Nuclear Proteins | 16 | 2023 | 5782 | 1.770 |
Why?
|
| Genes, Viral | 32 | 2019 | 654 | 1.720 |
Why?
|
| Herpesviridae | 5 | 2019 | 104 | 1.690 |
Why?
|
| Viral Vaccines | 12 | 2021 | 596 | 1.500 |
Why?
|
| Defective Viruses | 10 | 2007 | 89 | 1.470 |
Why?
|
| Herpes Simplex Virus Vaccines | 7 | 2019 | 17 | 1.450 |
Why?
|
| Cell Line | 71 | 2021 | 15540 | 1.400 |
Why?
|
| DNA Viruses | 4 | 2022 | 32 | 1.200 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 5 | 2015 | 27 | 1.170 |
Why?
|
| Epigenesis, Genetic | 10 | 2024 | 3816 | 1.120 |
Why?
|
| Immunity, Innate | 12 | 2021 | 3078 | 1.110 |
Why?
|
| Fibroblasts | 12 | 2021 | 4161 | 1.110 |
Why?
|
| DNA Replication | 33 | 2018 | 1428 | 1.100 |
Why?
|
| Chromatin | 9 | 2018 | 2979 | 1.090 |
Why?
|
| Genetic Vectors | 13 | 2021 | 3400 | 1.080 |
Why?
|
| Gene Silencing | 9 | 2021 | 1504 | 1.070 |
Why?
|
| Viruses | 6 | 2023 | 371 | 1.070 |
Why?
|
| DNA-Binding Proteins | 44 | 2015 | 9600 | 1.060 |
Why?
|
| Herpesviridae Infections | 2 | 2024 | 268 | 0.910 |
Why?
|
| Trigeminal Ganglion | 18 | 2019 | 189 | 0.890 |
Why?
|
| Promoter Regions, Genetic | 12 | 2016 | 5784 | 0.880 |
Why?
|
| Virus Activation | 12 | 2018 | 322 | 0.810 |
Why?
|
| Interferon Regulatory Factor-3 | 4 | 2017 | 145 | 0.810 |
Why?
|
| Immune Evasion | 6 | 2021 | 376 | 0.790 |
Why?
|
| Transcription, Genetic | 20 | 2018 | 7599 | 0.790 |
Why?
|
| Animals | 172 | 2024 | 168735 | 0.790 |
Why?
|
| Lamin Type A | 4 | 2015 | 186 | 0.770 |
Why?
|
| Interferon Type I | 8 | 2021 | 567 | 0.750 |
Why?
|
| Antiviral Agents | 9 | 2023 | 3053 | 0.750 |
Why?
|
| Viral Envelope Proteins | 14 | 2021 | 639 | 0.740 |
Why?
|
| TNF Receptor-Associated Factor 6 | 2 | 2013 | 59 | 0.720 |
Why?
|
| Nucleotidyltransferases | 3 | 2023 | 242 | 0.700 |
Why?
|
| Vaccines, Virus-Like Particle | 2 | 2021 | 44 | 0.700 |
Why?
|
| Toll-Like Receptor 2 | 8 | 2013 | 347 | 0.700 |
Why?
|
| RNA, Viral | 20 | 2021 | 2866 | 0.680 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2021 | 303 | 0.660 |
Why?
|
| Proviruses | 1 | 2021 | 319 | 0.640 |
Why?
|
| Bacteriophages | 1 | 2022 | 381 | 0.640 |
Why?
|
| Immunization | 11 | 2019 | 1218 | 0.630 |
Why?
|
| Viral Structural Proteins | 5 | 2016 | 93 | 0.610 |
Why?
|
| Cytomegalovirus | 6 | 2017 | 753 | 0.600 |
Why?
|
| Active Transport, Cell Nucleus | 5 | 2019 | 431 | 0.580 |
Why?
|
| Ribonucleases | 3 | 2016 | 265 | 0.570 |
Why?
|
| Ganglia | 2 | 2015 | 86 | 0.560 |
Why?
|
| Mice, Inbred BALB C | 23 | 2017 | 6209 | 0.550 |
Why?
|
| Antibodies, Viral | 20 | 2021 | 3213 | 0.540 |
Why?
|
| Keratitis, Herpetic | 6 | 2007 | 76 | 0.540 |
Why?
|
| Mice | 83 | 2024 | 81782 | 0.510 |
Why?
|
| West Nile virus | 1 | 2016 | 77 | 0.510 |
Why?
|
| Histones | 7 | 2021 | 2590 | 0.510 |
Why?
|
| Signal Transduction | 15 | 2021 | 23597 | 0.500 |
Why?
|
| Host Cell Factor C1 | 1 | 2015 | 35 | 0.490 |
Why?
|
| RNA Viruses | 2 | 2014 | 110 | 0.490 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2015 | 61 | 0.480 |
Why?
|
| Antibodies, Neutralizing | 4 | 2021 | 2010 | 0.470 |
Why?
|
| DNA Virus Infections | 1 | 2014 | 15 | 0.460 |
Why?
|
| Interferon-beta | 3 | 2017 | 346 | 0.460 |
Why?
|
| Vaccines, Attenuated | 7 | 2017 | 313 | 0.450 |
Why?
|
| Mutation | 51 | 2019 | 30192 | 0.450 |
Why?
|
| Simian virus 40 | 2 | 2013 | 290 | 0.450 |
Why?
|
| Virus Diseases | 3 | 2023 | 718 | 0.450 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2015 | 168 | 0.450 |
Why?
|
| Ebolavirus | 2 | 2022 | 250 | 0.440 |
Why?
|
| Protein Multimerization | 1 | 2019 | 959 | 0.440 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2015 | 149 | 0.430 |
Why?
|
| Herpes Labialis | 1 | 2012 | 28 | 0.410 |
Why?
|
| Transfection | 20 | 2015 | 5738 | 0.400 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2014 | 164 | 0.400 |
Why?
|
| RNA, Messenger | 24 | 2009 | 12768 | 0.390 |
Why?
|
| Cations, Divalent | 1 | 2012 | 167 | 0.390 |
Why?
|
| Humans | 123 | 2024 | 765926 | 0.390 |
Why?
|
| Recombination, Genetic | 8 | 2015 | 1525 | 0.380 |
Why?
|
| Osteosarcoma | 3 | 2015 | 908 | 0.380 |
Why?
|
| DNA Damage | 2 | 2021 | 2462 | 0.380 |
Why?
|
| Cytoplasm | 8 | 2015 | 1498 | 0.370 |
Why?
|
| AIDS Vaccines | 2 | 2009 | 898 | 0.370 |
Why?
|
| Capsid Proteins | 4 | 2019 | 467 | 0.370 |
Why?
|
| Cells, Cultured | 19 | 2021 | 18962 | 0.360 |
Why?
|
| Down-Regulation | 2 | 2016 | 2925 | 0.360 |
Why?
|
| Complement C3 | 3 | 2008 | 424 | 0.360 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 2897 | 0.360 |
Why?
|
| Gene Deletion | 7 | 2007 | 2667 | 0.360 |
Why?
|
| Immunoprecipitation | 5 | 2015 | 871 | 0.360 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 698 | 0.350 |
Why?
|
| Repressor Proteins | 2 | 2021 | 2969 | 0.350 |
Why?
|
| HEK293 Cells | 8 | 2021 | 4257 | 0.350 |
Why?
|
| HIV | 2 | 2017 | 1587 | 0.350 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 424 | 0.340 |
Why?
|
| Receptors, Complement 3d | 2 | 2008 | 116 | 0.340 |
Why?
|
| Proteome | 3 | 2015 | 1896 | 0.330 |
Why?
|
| Base Sequence | 20 | 2019 | 12405 | 0.330 |
Why?
|
| Fluorescent Antibody Technique | 14 | 2015 | 2470 | 0.330 |
Why?
|
| Virulence Factors | 1 | 2013 | 499 | 0.320 |
Why?
|
| DNA Helicases | 6 | 2016 | 852 | 0.310 |
Why?
|
| Amino Acid Sequence | 14 | 2021 | 13398 | 0.310 |
Why?
|
| Molecular Sequence Data | 18 | 2015 | 17596 | 0.300 |
Why?
|
| Cell Fusion | 4 | 2021 | 294 | 0.300 |
Why?
|
| Adenosine Triphosphatases | 2 | 2016 | 839 | 0.290 |
Why?
|
| Plasmids | 13 | 2013 | 2267 | 0.290 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 4 | 2013 | 425 | 0.290 |
Why?
|
| Oncolytic Viruses | 2 | 2024 | 344 | 0.290 |
Why?
|
| Gene Expression | 9 | 2024 | 7581 | 0.280 |
Why?
|
| NF-kappa B | 4 | 2018 | 2492 | 0.280 |
Why?
|
| Green Fluorescent Proteins | 3 | 2009 | 2062 | 0.280 |
Why?
|
| Trans-Activators | 4 | 2024 | 2848 | 0.270 |
Why?
|
| Thymidine Kinase | 9 | 2003 | 286 | 0.270 |
Why?
|
| Encephalitis, Viral | 3 | 2004 | 59 | 0.270 |
Why?
|
| HeLa Cells | 6 | 2018 | 3070 | 0.260 |
Why?
|
| MicroRNAs | 6 | 2024 | 3788 | 0.260 |
Why?
|
| Receptors, Complement 3b | 1 | 2006 | 124 | 0.260 |
Why?
|
| Cell Transformation, Viral | 7 | 2000 | 527 | 0.260 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 147 | 0.250 |
Why?
|
| Virus Physiological Phenomena | 2 | 2021 | 15 | 0.250 |
Why?
|
| RNA, Small Interfering | 5 | 2018 | 3419 | 0.250 |
Why?
|
| Genes, Reporter | 2 | 2010 | 1524 | 0.250 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2011 | 723 | 0.250 |
Why?
|
| Vesicular stomatitis Indiana virus | 8 | 1978 | 93 | 0.240 |
Why?
|
| Receptor, Interferon alpha-beta | 3 | 2017 | 113 | 0.240 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2013 | 632 | 0.240 |
Why?
|
| Genetic Engineering | 2 | 2019 | 933 | 0.240 |
Why?
|
| Gene Expression Regulation | 10 | 2019 | 11895 | 0.240 |
Why?
|
| Sendai virus | 1 | 2004 | 22 | 0.240 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2004 | 83 | 0.230 |
Why?
|
| Immunity, Cellular | 4 | 2018 | 1555 | 0.230 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 3716 | 0.230 |
Why?
|
| Viral Fusion Proteins | 3 | 2005 | 100 | 0.230 |
Why?
|
| Disease Models, Animal | 17 | 2019 | 18292 | 0.230 |
Why?
|
| Blotting, Western | 8 | 2013 | 5019 | 0.220 |
Why?
|
| DNA-Directed DNA Polymerase | 3 | 1998 | 481 | 0.220 |
Why?
|
| Vaccines, Synthetic | 3 | 2001 | 622 | 0.220 |
Why?
|
| Binding Sites | 8 | 2018 | 5999 | 0.220 |
Why?
|
| Interferons | 4 | 2023 | 714 | 0.220 |
Why?
|
| Exodeoxyribonucleases | 3 | 2004 | 191 | 0.210 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 457 | 0.210 |
Why?
|
| Vesiculovirus | 2 | 2021 | 52 | 0.210 |
Why?
|
| Immunoblotting | 3 | 2015 | 1643 | 0.210 |
Why?
|
| Protein Interaction Mapping | 2 | 2016 | 618 | 0.210 |
Why?
|
| Protein Biosynthesis | 4 | 2008 | 2089 | 0.210 |
Why?
|
| DNA Repair | 2 | 2019 | 2048 | 0.210 |
Why?
|
| Virology | 1 | 2023 | 76 | 0.200 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2559 | 0.200 |
Why?
|
| Sequence Deletion | 4 | 2011 | 1494 | 0.200 |
Why?
|
| Antibody Formation | 2 | 2006 | 1392 | 0.200 |
Why?
|
| G1 Phase | 2 | 2001 | 403 | 0.200 |
Why?
|
| Phosphorylation | 10 | 2021 | 8279 | 0.200 |
Why?
|
| Epithelial Cells | 3 | 2022 | 3684 | 0.200 |
Why?
|
| Orthobunyavirus | 1 | 2021 | 1 | 0.190 |
Why?
|
| Bunyaviridae Infections | 1 | 2021 | 2 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 8 | 2023 | 4641 | 0.190 |
Why?
|
| Eukaryota | 1 | 2022 | 101 | 0.190 |
Why?
|
| Keratinocytes | 2 | 2017 | 861 | 0.190 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 651 | 0.190 |
Why?
|
| Eukaryotic Cells | 1 | 2022 | 192 | 0.190 |
Why?
|
| Interferon-gamma | 7 | 2023 | 3158 | 0.180 |
Why?
|
| Foreskin | 1 | 2021 | 33 | 0.180 |
Why?
|
| Chemokines | 2 | 2005 | 956 | 0.180 |
Why?
|
| Mutagenesis | 3 | 2019 | 1226 | 0.180 |
Why?
|
| Vaccines, DNA | 3 | 2008 | 279 | 0.180 |
Why?
|
| Animal Experimentation | 1 | 2020 | 46 | 0.180 |
Why?
|
| Genetic Testing | 1 | 2014 | 3594 | 0.180 |
Why?
|
| Toll-Like Receptors | 5 | 2014 | 582 | 0.170 |
Why?
|
| STAT1 Transcription Factor | 3 | 2017 | 340 | 0.170 |
Why?
|
| Orthomyxoviridae | 1 | 2021 | 147 | 0.170 |
Why?
|
| DNA | 4 | 2023 | 7193 | 0.170 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 304 | 0.170 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2021 | 163 | 0.170 |
Why?
|
| Genetic Variation | 1 | 2015 | 6612 | 0.170 |
Why?
|
| Membrane Glycoproteins | 5 | 2014 | 3690 | 0.170 |
Why?
|
| Genetic Complementation Test | 6 | 1998 | 556 | 0.170 |
Why?
|
| Immunologic Memory | 3 | 2021 | 1374 | 0.160 |
Why?
|
| Retinal Ganglion Cells | 1 | 2005 | 811 | 0.160 |
Why?
|
| SAIDS Vaccines | 3 | 2006 | 144 | 0.160 |
Why?
|
| Viremia | 2 | 2019 | 727 | 0.160 |
Why?
|
| Cell Line, Tumor | 8 | 2024 | 17060 | 0.160 |
Why?
|
| Models, Genetic | 2 | 2019 | 3447 | 0.160 |
Why?
|
| MART-1 Antigen | 1 | 2019 | 62 | 0.160 |
Why?
|
| Immunoglobulin G | 7 | 2019 | 4555 | 0.160 |
Why?
|
| Protein Binding | 5 | 2021 | 9296 | 0.160 |
Why?
|
| Dendritic Cells | 4 | 2015 | 2745 | 0.160 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2018 | 58 | 0.160 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2021 | 254 | 0.160 |
Why?
|
| Transcription Factors | 5 | 2024 | 12129 | 0.150 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 213 | 0.150 |
Why?
|
| Injections, Intramuscular | 3 | 2017 | 551 | 0.150 |
Why?
|
| Organoids | 1 | 2024 | 740 | 0.150 |
Why?
|
| Capsid | 4 | 2016 | 435 | 0.150 |
Why?
|
| Th1 Cells | 3 | 2018 | 1040 | 0.150 |
Why?
|
| Antigens, Viral | 5 | 2021 | 995 | 0.150 |
Why?
|
| Oncolytic Virotherapy | 1 | 2024 | 520 | 0.150 |
Why?
|
| Cytokines | 6 | 2021 | 7417 | 0.150 |
Why?
|
| DNA, Bacterial | 2 | 2022 | 1476 | 0.150 |
Why?
|
| RNA Precursors | 1 | 2019 | 196 | 0.150 |
Why?
|
| RNA Polymerase II | 1 | 2002 | 549 | 0.150 |
Why?
|
| Conserved Sequence | 2 | 2012 | 1159 | 0.140 |
Why?
|
| Proteomics | 3 | 2015 | 3906 | 0.140 |
Why?
|
| RNA Interference | 2 | 2018 | 2829 | 0.140 |
Why?
|
| Co-Repressor Proteins | 1 | 2018 | 189 | 0.140 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2018 | 146 | 0.140 |
Why?
|
| Receptors, Interferon | 1 | 2017 | 114 | 0.140 |
Why?
|
| Neurons | 6 | 2024 | 9527 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 856 | 0.140 |
Why?
|
| Nuclear Lamina | 3 | 2009 | 47 | 0.140 |
Why?
|
| Cell Compartmentation | 4 | 2003 | 383 | 0.140 |
Why?
|
| Cell Line, Transformed | 3 | 2008 | 858 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 14 | 2021 | 22327 | 0.140 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2015 | 1724 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 3 | 2014 | 2627 | 0.130 |
Why?
|
| Time Factors | 12 | 2015 | 40097 | 0.130 |
Why?
|
| Glycoproteins | 7 | 2015 | 2196 | 0.130 |
Why?
|
| Peripheral Nervous System | 1 | 2017 | 151 | 0.130 |
Why?
|
| Gene Order | 1 | 2016 | 164 | 0.130 |
Why?
|
| Myeloid Cells | 3 | 2022 | 838 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 798 | 0.120 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2020 | 1440 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 1415 | 0.120 |
Why?
|
| Transgenes | 1 | 2019 | 1014 | 0.120 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 2015 | 25 | 0.120 |
Why?
|
| Cell Cycle | 3 | 2000 | 2920 | 0.120 |
Why?
|
| Mice, Knockout | 8 | 2018 | 14450 | 0.120 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 1008 | 0.120 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2017 | 547 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3801 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2016 | 1961 | 0.120 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1787 | 0.120 |
Why?
|
| Transcriptional Activation | 3 | 2008 | 1743 | 0.120 |
Why?
|
| Open Reading Frames | 3 | 2013 | 820 | 0.110 |
Why?
|
| Research | 1 | 2023 | 1974 | 0.110 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2014 | 110 | 0.110 |
Why?
|
| Serial Passage | 1 | 2013 | 22 | 0.110 |
Why?
|
| Vaccination | 5 | 2019 | 3430 | 0.110 |
Why?
|
| Receptors, Cell Surface | 3 | 2012 | 2814 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2006 | 3733 | 0.110 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2014 | 63 | 0.110 |
Why?
|
| Flow Cytometry | 3 | 2013 | 5880 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 780 | 0.110 |
Why?
|
| Genes | 5 | 1989 | 1824 | 0.110 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2015 | 168 | 0.110 |
Why?
|
| Gene Targeting | 3 | 2019 | 840 | 0.110 |
Why?
|
| Heparitin Sulfate | 1 | 2015 | 223 | 0.110 |
Why?
|
| Phylogeny | 2 | 2019 | 2837 | 0.110 |
Why?
|
| Microscopy | 1 | 2019 | 900 | 0.110 |
Why?
|
| Blotting, Northern | 2 | 2019 | 1546 | 0.110 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 760 | 0.110 |
Why?
|
| Virus Assembly | 2 | 2005 | 140 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 505 | 0.110 |
Why?
|
| Melanoma | 4 | 2024 | 5695 | 0.110 |
Why?
|
| Bacteria | 2 | 2022 | 2210 | 0.110 |
Why?
|
| Mammalian orthoreovirus 3 | 2 | 2002 | 45 | 0.110 |
Why?
|
| Guinea Pigs | 5 | 2014 | 1300 | 0.110 |
Why?
|
| Genes, Regulator | 2 | 1993 | 373 | 0.100 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 1882 | 0.100 |
Why?
|
| Interleukin-2 | 1 | 2020 | 1894 | 0.100 |
Why?
|
| Geography | 1 | 2015 | 651 | 0.100 |
Why?
|
| Reoviridae Infections | 2 | 2002 | 59 | 0.100 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2014 | 260 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 606 | 0.100 |
Why?
|
| Liposomes | 2 | 2015 | 786 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2014 | 486 | 0.100 |
Why?
|
| Herpesvirus 8, Human | 1 | 2014 | 254 | 0.100 |
Why?
|
| Virion | 2 | 2006 | 428 | 0.100 |
Why?
|
| Monocytes | 1 | 2022 | 2591 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1673 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 1884 | 0.100 |
Why?
|
| Cancer Vaccines | 2 | 2020 | 1042 | 0.100 |
Why?
|
| Polyethyleneimine | 1 | 2012 | 70 | 0.100 |
Why?
|
| Complement System Proteins | 3 | 2006 | 716 | 0.100 |
Why?
|
| Genetic Markers | 3 | 2015 | 2603 | 0.100 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 2543 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 4 | 2014 | 6058 | 0.100 |
Why?
|
| Cytomegalovirus Infections | 3 | 2017 | 837 | 0.100 |
Why?
|
| Neutralization Tests | 2 | 2007 | 735 | 0.090 |
Why?
|
| Sensory Receptor Cells | 1 | 2016 | 510 | 0.090 |
Why?
|
| Neurons, Afferent | 3 | 2003 | 496 | 0.090 |
Why?
|
| beta-Galactosidase | 4 | 2002 | 573 | 0.090 |
Why?
|
| Epitopes | 2 | 2011 | 2523 | 0.090 |
Why?
|
| Interleukin-17 | 1 | 2017 | 921 | 0.090 |
Why?
|
| In Situ Hybridization | 5 | 2000 | 1885 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2019 | 1866 | 0.090 |
Why?
|
| Vagina | 5 | 2014 | 849 | 0.090 |
Why?
|
| Biological Transport | 4 | 2005 | 2081 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 4780 | 0.090 |
Why?
|
| Antigens, CD1d | 1 | 2011 | 226 | 0.090 |
Why?
|
| Urine | 1 | 2012 | 363 | 0.090 |
Why?
|
| Male | 24 | 2024 | 363815 | 0.090 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 839 | 0.090 |
Why?
|
| Rabbits | 4 | 2014 | 4729 | 0.080 |
Why?
|
| Apoptosis | 2 | 2024 | 9505 | 0.080 |
Why?
|
| Peptides | 4 | 2020 | 4331 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1997 | 1812 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 924 | 0.080 |
Why?
|
| Janus Kinase 1 | 1 | 2009 | 108 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 566 | 0.080 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2010 | 175 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4520 | 0.080 |
Why?
|
| Female | 30 | 2021 | 396141 | 0.080 |
Why?
|
| Acetylation | 2 | 2009 | 1054 | 0.080 |
Why?
|
| Immunogenetics | 1 | 2009 | 62 | 0.080 |
Why?
|
| Viral Load | 5 | 2019 | 3385 | 0.080 |
Why?
|
| Skin | 2 | 2021 | 4481 | 0.080 |
Why?
|
| Simian immunodeficiency virus | 2 | 2006 | 812 | 0.080 |
Why?
|
| Telomere | 1 | 2014 | 941 | 0.080 |
Why?
|
| T-Lymphocytes | 5 | 2019 | 10256 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2013 | 996 | 0.080 |
Why?
|
| Antigens, Surface | 1 | 2012 | 1616 | 0.070 |
Why?
|
| Membrane Fusion | 2 | 2006 | 264 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 3749 | 0.070 |
Why?
|
| Ubiquitins | 1 | 2009 | 365 | 0.070 |
Why?
|
| Macrophages | 3 | 2016 | 5772 | 0.070 |
Why?
|
| CDC2 Protein Kinase | 1 | 2009 | 212 | 0.070 |
Why?
|
| Phosphonoacetic Acid | 2 | 1996 | 54 | 0.070 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 210 | 0.070 |
Why?
|
| Natural Killer T-Cells | 1 | 2011 | 319 | 0.070 |
Why?
|
| Interleukin-8 | 2 | 2008 | 699 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2012 | 2172 | 0.070 |
Why?
|
| Trigeminal Nerve | 1 | 1989 | 253 | 0.070 |
Why?
|
| Antigen Presentation | 2 | 2011 | 1250 | 0.070 |
Why?
|
| Virulence | 1 | 2011 | 1289 | 0.070 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2001 | 659 | 0.070 |
Why?
|
| Leukemia | 1 | 2015 | 1522 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2019 | 4405 | 0.070 |
Why?
|
| Macaca mulatta | 3 | 2010 | 2341 | 0.070 |
Why?
|
| Ouabain | 1 | 2007 | 246 | 0.070 |
Why?
|
| Mice, Inbred ICR | 2 | 2004 | 341 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 2184 | 0.070 |
Why?
|
| Leupeptins | 1 | 2006 | 112 | 0.070 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2007 | 136 | 0.070 |
Why?
|
| Cornea | 5 | 2004 | 1315 | 0.070 |
Why?
|
| Cell Membrane | 8 | 2014 | 3635 | 0.070 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 433 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2006 | 185 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2005 | 1769 | 0.070 |
Why?
|
| Replicon | 1 | 2006 | 35 | 0.070 |
Why?
|
| Central Nervous System | 2 | 2011 | 1343 | 0.070 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 6491 | 0.060 |
Why?
|
| Palmitic Acid | 1 | 2006 | 147 | 0.060 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2009 | 381 | 0.060 |
Why?
|
| Viral Regulatory and Accessory Proteins | 2 | 2006 | 151 | 0.060 |
Why?
|
| Eye | 3 | 2003 | 709 | 0.060 |
Why?
|
| Phenotype | 8 | 2021 | 16714 | 0.060 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2005 | 71 | 0.060 |
Why?
|
| DNA Primase | 2 | 1996 | 110 | 0.060 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2015 | 1504 | 0.060 |
Why?
|
| South Africa | 1 | 2011 | 1868 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2012 | 1970 | 0.060 |
Why?
|
| Tritium | 2 | 2006 | 702 | 0.060 |
Why?
|
| Temperature | 9 | 1986 | 2226 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2019 | 1852 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2006 | 1800 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2022 | 1336 | 0.060 |
Why?
|
| RNA Splicing | 1 | 2009 | 902 | 0.060 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2004 | 35 | 0.060 |
Why?
|
| Papillomavirus Vaccines | 1 | 2011 | 495 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2004 | 47 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2004 | 68 | 0.060 |
Why?
|
| Spinal Cord | 2 | 2002 | 1786 | 0.060 |
Why?
|
| RecQ Helicases | 1 | 2004 | 54 | 0.060 |
Why?
|
| HIV-1 | 2 | 2019 | 6945 | 0.060 |
Why?
|
| Lac Operon | 2 | 1997 | 237 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2016 | 2194 | 0.060 |
Why?
|
| Cloning, Molecular | 4 | 1993 | 4163 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1990 | 1305 | 0.050 |
Why?
|
| Cell Survival | 2 | 2015 | 5745 | 0.050 |
Why?
|
| Antigens, Nuclear | 1 | 2004 | 182 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2008 | 909 | 0.050 |
Why?
|
| Transplantation Chimera | 1 | 2006 | 609 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 1996 | 484 | 0.050 |
Why?
|
| United States | 3 | 2020 | 72909 | 0.050 |
Why?
|
| Neuritis | 1 | 2003 | 35 | 0.050 |
Why?
|
| Species Specificity | 2 | 2022 | 2406 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2006 | 1677 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 8722 | 0.050 |
Why?
|
| Blotting, Southern | 3 | 2000 | 772 | 0.050 |
Why?
|
| Precipitin Tests | 2 | 2002 | 812 | 0.050 |
Why?
|
| Nerve Endings | 1 | 2002 | 103 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 3 | 2006 | 2729 | 0.050 |
Why?
|
| Microscopy, Video | 1 | 2003 | 241 | 0.050 |
Why?
|
| Perforin | 1 | 2023 | 166 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2012 | 2589 | 0.050 |
Why?
|
| Holoenzymes | 1 | 2002 | 39 | 0.050 |
Why?
|
| Alphaherpesvirinae | 1 | 2021 | 9 | 0.050 |
Why?
|
| Complement C4 | 1 | 2002 | 208 | 0.050 |
Why?
|
| Protein Conformation | 3 | 2003 | 3945 | 0.050 |
Why?
|
| RNA | 1 | 2012 | 2716 | 0.050 |
Why?
|
| B-Lymphocytes | 3 | 2022 | 4782 | 0.050 |
Why?
|
| Serine | 2 | 1996 | 825 | 0.050 |
Why?
|
| Lymphocyte Activation | 4 | 2011 | 5500 | 0.050 |
Why?
|
| Virus Shedding | 2 | 2014 | 111 | 0.050 |
Why?
|
| DNA, Recombinant | 3 | 2016 | 455 | 0.050 |
Why?
|
| Vesicular Stomatitis | 1 | 2021 | 18 | 0.050 |
Why?
|
| Point Mutation | 2 | 2005 | 1590 | 0.050 |
Why?
|
| Organic Cation Transporter 1 | 1 | 2021 | 7 | 0.050 |
Why?
|
| Proline | 1 | 2003 | 452 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 939 | 0.050 |
Why?
|
| Ganglia, Sensory | 1 | 2000 | 20 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2010 | 1590 | 0.050 |
Why?
|
| Uridine | 1 | 2001 | 135 | 0.050 |
Why?
|
| Caspases | 1 | 2024 | 880 | 0.040 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2006 | 543 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2006 | 1332 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2023 | 581 | 0.040 |
Why?
|
| Camelids, New World | 1 | 2020 | 20 | 0.040 |
Why?
|
| Molecular Weight | 6 | 1985 | 2160 | 0.040 |
Why?
|
| Gene Expression Profiling | 4 | 2022 | 9525 | 0.040 |
Why?
|
| Electrophoresis | 1 | 2000 | 226 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2017 | 65194 | 0.040 |
Why?
|
| Inflammation | 3 | 2022 | 10843 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2001 | 449 | 0.040 |
Why?
|
| Kinetics | 5 | 2006 | 6273 | 0.040 |
Why?
|
| DNA Primers | 3 | 2014 | 2824 | 0.040 |
Why?
|
| Escherichia coli | 4 | 2016 | 4210 | 0.040 |
Why?
|
| Vaccines, Subunit | 1 | 2020 | 159 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4249 | 0.040 |
Why?
|
| Leukocytes | 2 | 2004 | 2027 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 1982 | 4909 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7847 | 0.040 |
Why?
|
| Brain | 2 | 2024 | 27179 | 0.040 |
Why?
|
| Policy Making | 1 | 2023 | 546 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2002 | 623 | 0.040 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2019 | 35 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2018 | 71 | 0.040 |
Why?
|
| Pandemics | 3 | 2023 | 8721 | 0.040 |
Why?
|
| Poly A | 1 | 1998 | 180 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2024 | 1349 | 0.040 |
Why?
|
| Influenza A virus | 1 | 2022 | 453 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2001 | 666 | 0.040 |
Why?
|
| Actins | 1 | 2005 | 2057 | 0.040 |
Why?
|
| STAT2 Transcription Factor | 1 | 2017 | 27 | 0.040 |
Why?
|
| Viridans Streptococci | 1 | 2017 | 16 | 0.040 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2014 | 582 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2001 | 561 | 0.040 |
Why?
|
| Organophosphorus Compounds | 1 | 1979 | 209 | 0.040 |
Why?
|
| Genomics | 1 | 2013 | 5925 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2019 | 316 | 0.040 |
Why?
|
| Cyclins | 1 | 2000 | 598 | 0.040 |
Why?
|
| Bone Marrow Cells | 2 | 2003 | 2411 | 0.040 |
Why?
|
| Genitalia | 1 | 1998 | 114 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2019 | 2676 | 0.040 |
Why?
|
| Immune Sera | 1 | 1997 | 601 | 0.040 |
Why?
|
| Nasal Mucosa | 1 | 2000 | 416 | 0.040 |
Why?
|
| Axons | 1 | 2005 | 1678 | 0.040 |
Why?
|
| Neoplasms | 2 | 2023 | 22340 | 0.030 |
Why?
|
| Keratitis, Dendritic | 2 | 1986 | 18 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 3 | 1984 | 548 | 0.030 |
Why?
|
| Acyclovir | 2 | 2005 | 266 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 10380 | 0.030 |
Why?
|
| Asparagine | 1 | 2016 | 120 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 9541 | 0.030 |
Why?
|
| Chromosome Deletion | 3 | 1992 | 1384 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 733 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 6101 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 1979 | 429 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 5836 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 608 | 0.030 |
Why?
|
| Injections, Intravenous | 3 | 2003 | 1376 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 1997 | 606 | 0.030 |
Why?
|
| S Phase | 1 | 1997 | 423 | 0.030 |
Why?
|
| DNA, Single-Stranded | 2 | 1989 | 351 | 0.030 |
Why?
|
| Peptide Mapping | 1 | 1996 | 259 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2020 | 1751 | 0.030 |
Why?
|
| Autoantigens | 1 | 2020 | 886 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 1997 | 616 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2019 | 960 | 0.030 |
Why?
|
| Neurites | 1 | 2017 | 389 | 0.030 |
Why?
|
| Models, Biological | 4 | 2010 | 9443 | 0.030 |
Why?
|
| RNA, Double-Stranded | 1 | 2016 | 292 | 0.030 |
Why?
|
| Interleukin-6 | 3 | 2005 | 3225 | 0.030 |
Why?
|
| Tranylcypromine | 1 | 2014 | 30 | 0.030 |
Why?
|
| Autoimmune Diseases | 2 | 2024 | 2248 | 0.030 |
Why?
|
| Serine Proteases | 1 | 2014 | 43 | 0.030 |
Why?
|
| Chimera | 2 | 2001 | 455 | 0.030 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1994 | 45 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2024 | 2430 | 0.030 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2014 | 152 | 0.030 |
Why?
|
| Cell Fractionation | 3 | 1982 | 244 | 0.030 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2014 | 88 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 1998 | 498 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2023 | 1142 | 0.030 |
Why?
|
| Acute Disease | 2 | 2019 | 7236 | 0.030 |
Why?
|
| Stilbamidines | 1 | 1994 | 45 | 0.030 |
Why?
|
| Telomere-Binding Proteins | 1 | 2014 | 122 | 0.030 |
Why?
|
| RNA Probes | 1 | 1993 | 110 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2019 | 1075 | 0.030 |
Why?
|
| Morbidity | 1 | 2019 | 1752 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 1994 | 410 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7473 | 0.030 |
Why?
|
| HMGB2 Protein | 1 | 2012 | 7 | 0.030 |
Why?
|
| Radiation Chimera | 2 | 2003 | 216 | 0.030 |
Why?
|
| Mice, SCID | 3 | 2008 | 2626 | 0.030 |
Why?
|
| Protein Transport | 2 | 2011 | 1938 | 0.030 |
Why?
|
| Chromosome Aberrations | 2 | 2014 | 1775 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2017 | 616 | 0.030 |
Why?
|
| HIV Infections | 1 | 2019 | 17531 | 0.030 |
Why?
|
| Chaperonins | 1 | 2012 | 58 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 780 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1993 | 151 | 0.030 |
Why?
|
| Spleen | 3 | 2008 | 2294 | 0.020 |
Why?
|
| Immunoglobulin Class Switching | 1 | 1994 | 289 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 2 | 1989 | 832 | 0.020 |
Why?
|
| Restriction Mapping | 2 | 1989 | 848 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 1995 | 0.020 |
Why?
|
| Histone Demethylases | 1 | 2014 | 328 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2015 | 1346 | 0.020 |
Why?
|
| Stem Cells | 1 | 2024 | 3537 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2012 | 242 | 0.020 |
Why?
|
| trans-Golgi Network | 1 | 2011 | 33 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 705 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3604 | 0.020 |
Why?
|
| Genes, pol | 1 | 1991 | 53 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1996 | 1202 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 454 | 0.020 |
Why?
|
| Necrosis | 1 | 2015 | 1611 | 0.020 |
Why?
|
| Endosomes | 1 | 2014 | 521 | 0.020 |
Why?
|
| DNA Polymerase II | 1 | 1991 | 103 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2003 | 4563 | 0.020 |
Why?
|
| Bacteremia | 1 | 2017 | 988 | 0.020 |
Why?
|
| Proteolipids | 1 | 2010 | 109 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 2001 | 0.020 |
Why?
|
| Condoms | 1 | 2012 | 336 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2024 | 3444 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 422 | 0.020 |
Why?
|
| Chickens | 1 | 1992 | 842 | 0.020 |
Why?
|
| Recurrence | 2 | 2014 | 8492 | 0.020 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2010 | 140 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1601 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2010 | 212 | 0.020 |
Why?
|
| Cytosol | 1 | 2012 | 885 | 0.020 |
Why?
|
| Surface Properties | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Fungi | 1 | 2012 | 347 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2017 | 1264 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 1993 | 3049 | 0.020 |
Why?
|
| Ribonucleosides | 1 | 2009 | 79 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1988 | 220 | 0.020 |
Why?
|
| Encephalitis | 1 | 2012 | 440 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 712 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 1988 | 310 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 4 | 1978 | 1132 | 0.020 |
Why?
|
| Carrier State | 1 | 2011 | 529 | 0.020 |
Why?
|
| Immunohistochemistry | 4 | 2006 | 11030 | 0.020 |
Why?
|
| Acetyltransferases | 1 | 1988 | 230 | 0.020 |
Why?
|
| Virus Attachment | 1 | 2007 | 55 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 740 | 0.020 |
Why?
|
| Genotype | 2 | 2018 | 13026 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 1674 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1988 | 1430 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2005 | 149 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2006 | 389 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 1331 | 0.020 |
Why?
|
| Haplorhini | 2 | 1983 | 520 | 0.010 |
Why?
|
| Membrane Transport Proteins | 1 | 2010 | 1028 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1984 | 30 | 0.010 |
Why?
|
| Genes, Essential | 1 | 2005 | 185 | 0.010 |
Why?
|
| Autoradiography | 2 | 1975 | 723 | 0.010 |
Why?
|
| Anxiety | 1 | 2019 | 4669 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1985 | 1140 | 0.010 |
Why?
|
| Antibody-Producing Cells | 1 | 2003 | 139 | 0.010 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2003 | 50 | 0.010 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2005 | 197 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 2003 | 67 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2009 | 862 | 0.010 |
Why?
|
| Virus Internalization | 1 | 2007 | 502 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1994 | 1657 | 0.010 |
Why?
|
| Estrus | 1 | 2003 | 70 | 0.010 |
Why?
|
| Lung | 1 | 2022 | 10046 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 2002 | 70 | 0.010 |
Why?
|
| Reassortant Viruses | 1 | 2002 | 36 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1982 | 152 | 0.010 |
Why?
|
| Phenylacetates | 1 | 2002 | 112 | 0.010 |
Why?
|
| Haptens | 1 | 2002 | 163 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2012 | 2394 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1982 | 483 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2003 | 433 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 1983 | 228 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 3940 | 0.010 |
Why?
|
| Langerhans Cells | 1 | 2003 | 169 | 0.010 |
Why?
|
| Nitrophenols | 1 | 2002 | 169 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 2012 | 1736 | 0.010 |
Why?
|
| Endodeoxyribonucleases | 1 | 1983 | 165 | 0.010 |
Why?
|
| Detergents | 1 | 1982 | 235 | 0.010 |
Why?
|
| Cysteine | 1 | 2006 | 897 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 2005 | 575 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1886 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2004 | 602 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 3431 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1988 | 1363 | 0.010 |
Why?
|
| Lymphopenia | 1 | 2003 | 298 | 0.010 |
Why?
|
| Cell Movement | 2 | 2003 | 5190 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 1982 | 209 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 1740 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 587 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 827 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10426 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 1748 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 2003 | 658 | 0.010 |
Why?
|
| Introns | 1 | 2002 | 965 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1993 | 9239 | 0.010 |
Why?
|
| Retroviridae | 1 | 1982 | 845 | 0.010 |
Why?
|
| Lymph Nodes | 2 | 2003 | 3447 | 0.010 |
Why?
|
| Adult | 3 | 2022 | 223088 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2001 | 824 | 0.010 |
Why?
|
| Endocytosis | 1 | 2002 | 952 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2001 | 647 | 0.010 |
Why?
|
| Diploidy | 1 | 1978 | 141 | 0.010 |
Why?
|
| Cell-Free System | 2 | 1977 | 339 | 0.010 |
Why?
|
| Kidney | 2 | 1984 | 7073 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1994 | 8924 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2003 | 2232 | 0.010 |
Why?
|
| Pregnancy | 1 | 2019 | 30230 | 0.010 |
Why?
|
| Age Factors | 2 | 2005 | 18382 | 0.010 |
Why?
|
| Sialic Acids | 1 | 1977 | 119 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 1982 | 1077 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1996 | 316 | 0.010 |
Why?
|
| Carcinoma, Krebs 2 | 1 | 1975 | 8 | 0.010 |
Why?
|
| Polynucleotides | 1 | 1975 | 27 | 0.010 |
Why?
|
| Immunocompetence | 1 | 1996 | 138 | 0.010 |
Why?
|
| Centrifugation, Zonal | 1 | 1975 | 14 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1975 | 113 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1975 | 100 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1975 | 211 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3796 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2002 | 4016 | 0.010 |
Why?
|
| Trypsin | 1 | 1975 | 487 | 0.010 |
Why?
|
| Ficusin | 1 | 1994 | 15 | 0.010 |
Why?
|
| Galactosides | 1 | 1994 | 54 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 20133 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1978 | 1133 | 0.010 |
Why?
|
| Child | 1 | 2022 | 80568 | 0.010 |
Why?
|
| Immunoglobulins | 2 | 1986 | 853 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2005 | 26380 | 0.010 |
Why?
|
| Methionine | 1 | 1975 | 569 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1975 | 561 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1982 | 2838 | 0.010 |
Why?
|
| Cricetinae | 1 | 1975 | 2412 | 0.010 |
Why?
|
| Genetic Linkage | 2 | 1986 | 2342 | 0.010 |
Why?
|
| Ovary | 1 | 1975 | 961 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1056 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 4213 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4342 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 171163 | 0.000 |
Why?
|
| Up-Regulation | 1 | 1996 | 4130 | 0.000 |
Why?
|
| Middle Aged | 1 | 2021 | 223016 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1986 | 244 | 0.000 |
Why?
|
| Adenoviruses, Human | 1 | 1988 | 257 | 0.000 |
Why?
|
| H-2 Antigens | 1 | 1986 | 359 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 1927 | 0.000 |
Why?
|
| Indoles | 1 | 1994 | 1833 | 0.000 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1994 | 2423 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 9065 | 0.000 |
Why?
|
| Cell Division | 1 | 1989 | 4466 | 0.000 |
Why?
|
| Hydroxylamines | 1 | 1981 | 39 | 0.000 |
Why?
|
| Rats | 1 | 1996 | 23708 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 18074 | 0.000 |
Why?
|
| DNA, Circular | 1 | 1979 | 97 | 0.000 |
Why?
|
| Polyribosomes | 1 | 1977 | 109 | 0.000 |
Why?
|
| Intracellular Membranes | 1 | 1977 | 386 | 0.000 |
Why?
|
| Nucleic Acid Conformation | 1 | 1979 | 900 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1981 | 4617 | 0.000 |
Why?
|